Difgen Pharms Company Profile
✉ Email this page to a colleague
What is the competitive landscape for DIFGEN PHARMS, and what generic and branded alternatives to DIFGEN PHARMS drugs are available?
DIFGEN PHARMS has five approved drugs.
Summary for Difgen Pharms
| US Patents: | 0 |
| Tradenames: | 12 |
| Ingredients: | 5 |
| NDAs: | 5 |
Drugs and US Patents for Difgen Pharms
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Difgen Pharms | FENTANYL-87 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 077449-008 | Dec 6, 2017 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Difgen Pharms | NICOTINE | nicotine | FILM, EXTENDED RELEASE;TRANSDERMAL | 074612-002 | Jul 28, 2003 | OTC | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Difgen Pharms | FENTANYL-12 | fentanyl | FILM, EXTENDED RELEASE;TRANSDERMAL | 077449-005 | Sep 11, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Difgen Pharms | BUPRENORPHINE HYDROCHLORIDE AND NALOXONE HYDROCHLORIDE | buprenorphine hydrochloride; naloxone hydrochloride | FILM;BUCCAL, SUBLINGUAL | 212756-001 | Jun 2, 2022 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Difgen Pharms | BUPRENORPHINE | buprenorphine | FILM, EXTENDED RELEASE;TRANSDERMAL | 210272-001 | Sep 23, 2021 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| Difgen Pharms | CLONIDINE | clonidine | SYSTEM;TRANSDERMAL | 076157-003 | Aug 18, 2009 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
